Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cigna Set to Grab a Bigger Pie of Medicare Advantage Business

Published 10/13/2020, 01:50 AM
Updated 07/09/2023, 06:31 AM

Cigna Corp. CI will expand its Medicare Advantage (MA) health plan offerings to seniors in 67 new counties next year in what is quickly becoming a competitive business proposition for health insurance giants.

The MA health plan will be extended by increasing the company’s MA policy offerings for the 2021 MA enrollment season, which begins Oct 15 and runs through Dec 7. Plans selected during that time will be effective Jan 1, 2021.

Cigna has a relatively smaller share of the Medicare Advantage market, dominated by Humana Inc (NYSE:HUM). HUM and Centene (NYSE:CNC) Corp. CNC followed by UnitedHealth Group Inc. UNH.

However, the growing opportunities in this market are attracting Cigna to grab a greater slice of the MA market. An aging U.S. population and bipartisan support from the government made the MA market a prospective place to be which are the private version of the government sponsored Medicare plans. The company targets a 22% growth rate from the previous year in the MA business by offering plans in 369 counties covering 23 states. By 2024, it is targeting 50% of the market.

Margins provided by the MA plans are almost double the ones offered by individual and commercial group plans. And this high-margin business makes every health insurer vie for a pie of this market.

Thus the company will enter the MA markets in five new states during 2021. These are Ohio, Virginia, Oklahoma, Utah and New Mexico. It is already present in 18 states and the District of Columbia, and currently serves 5,00,000 MA customers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cigna is also broadening its portfolio with less restrictive preferred provider organization (PPO) products in 154 counties across its existing footprint. With geographical expansion, Cigna is set to enter 67 new counties in 2021, thus strengthening its presence with HMO and/or PPO plans.

While HMOs generally restrict choices of the medical care providers to health plan networks, PPOs can be more popular by allowing choices outside their network though generally at a greater cost to the health plan enrollees.

Cigna has been laying a groundwork to serve the MA customers by expanding its physicians’ network. It has more than 25,000 physicians throughout its service territory.

The company’s MA model works on value-based care for which, it is imperative to have a broad network of physicians. It currently has on its network more than 25,000 physicians who treat 85% of its customers. In the current COVID situation, the company provided efficient services to its MA members via all the modes of communication like in-person, over the phone or virtually.

Cigna also made the plan more attractive by reducing or keeping the premium unchanged with $0 premium plan available in every market and virtual care offered at no cost.

Several health plans including Aetna (NYSE:AET), Anthem, Centene, Humana and UnitedHealth Group are looking to expand their Medicare Advantage businesses next year.

The company boasts an impressive MA growth trajectory. It expects 10-15% average annual customer growth through 2025. It anticipates having 30 million MA enrollees by 2025. As of Jun 30, 2020, the company delivered 16% growth in MA customers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Year to date, the stock has gained 17.1% against its industry’s decline of 16.2%.

The stock carries a Zacks Rank #3 (Hold), currently. You can see the complete list of today’s Zacks #1 Rank (Srong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we're targeting >>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (NYSE:UNH): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Cigna Corporation (NYSE:CI): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.